All In Biotech

Drug Trial Radar · NCT07816185

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 376 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

376

Planned (sponsor's estimate)

Start

Aug 31, 2026

Primary completion

Jan 28, 2029

Study completion Aug 31, 2029

Sponsor

Lead sponsor
Pulmovant, Inc.Industry
Sponsor type
Industry
First posted
Sep 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

Conditions

  • Pulmonary Hypertension
  • Interstitial Lung Disease
  • Vascular Diseases
  • Cardiovascular Diseases
  • Fibrosis

Interventions

  • MosliciguatDrug

    Dose level 1, 2, or 3 for inhalation

  • PlaceboDrug

    Matching Placebo for inhalation

  • Dry Powder InhalerDevice

    Administration via dry powder inhaler

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in 6-Minute Walk Distance (6MWD)Time frame: Baseline to Week 24

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Site

    Kissimmee, Florida · Recruiting

  • Clinical Research Site

    Louisville, Kentucky · Recruiting

  • Clinical Research Site

    Bend, Oregon · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.